Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity ; volume:13 ; number:1 ; day:22 ; month:11 ; year:2022 ; pages:1-18 ; date:12.2022
Nature Communications ; 13, Heft 1 (22.11.2022), 1-18, 12.2022
- Creator
-
Svensson-Arvelund, Judit
Cuadrado-Castano, Sara
Pantsulaia, Gvantsa
Kim, Kristy
Aleynick, Mark
Hammerich, Linda
Upadhyay, Ranjan
Yellin, Michael
Marsh, Henry
Oreper, Daniel
Jhunjhunwala, Suchit
Moussion, Christine
Merad, Miriam
Brown, Brian D.
García-Sastre, Adolfo
Brody, Joshua D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-34791-8
- URN
-
urn:nbn:de:101:1-2023020409355553256981
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Svensson-Arvelund, Judit
- Cuadrado-Castano, Sara
- Pantsulaia, Gvantsa
- Kim, Kristy
- Aleynick, Mark
- Hammerich, Linda
- Upadhyay, Ranjan
- Yellin, Michael
- Marsh, Henry
- Oreper, Daniel
- Jhunjhunwala, Suchit
- Moussion, Christine
- Merad, Miriam
- Brown, Brian D.
- García-Sastre, Adolfo
- Brody, Joshua D.
- SpringerLink (Online service)
Other Objects (12)
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy
Analysis of different combinatory regimes on the antitumor efficacy of oncolytic YB-1 based virotherapy in glioblastoma
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy
Analysis of different combinatory regimes on the antitumor efficacy of oncolytic YB-1 based virotherapy in glioblastoma
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy
Analysis of different combinatory regimes on the antitumor efficacy of oncolytic YB-1 based virotherapy in glioblastoma
Effects of virus-induced immunogenic cues on oncolytic virotherapy